Isomorphic Labs signs AI drug discovery deals with Novartis, Lilly

Jan 10, 2024 · Alphabet subsidiary Isomorphic Labs has signed drug discovery collaborations potentially worth nearly $3 billion with Eli Lilly and Novartis. In the first deal, Isomorphic Labs …

CouponFollow Extension

$3
OFF

Isomorphic Labs Signs AI Drug Discovery Deals With Novartis, Lilly

4 weeks from now

Jan 10, 2024 · Alphabet subsidiary Isomorphic Labs has signed drug discovery collaborations potentially worth nearly $3 billion with Eli Lilly and Novartis. In the first deal, Isomorphic Labs …

pharmamanufacturing.com

$3
OFF

Isomorphic Signs $3B In AI Drug Discovery Pacts With Lilly, Novartis

4 weeks from now

Jan 7, 2024 · Alphabet's artificial intelligence (AI) start-up Isomorphic Labs has nabbed a pair of drug discovery deals with Eli Lilly and Novartis worth close to $3 billion. ... Isomorphic signs …

firstwordhealthtech.com

$3
OFF

DeepMind’s Isomorphic Inks $3B Worth Of Deals With Lilly And …

4 weeks from now

Jan 8, 2024 · With its first big deals since its launch about two years ago, AI spinout Isomorphic yesterday announced two agreements worth $3B worth with each Eli Lilly and Novartis to …

insideprecisionmedicine.com

$3
OFF

Alphabet’s AI Unit Isomorphic Inks Drug Discovery Deals With Eli …

4 weeks from now

January 7, 2024 MWBN Indiana News, News, Syndication Comments Off on Alphabet’s AI unit Isomorphic inks drug discovery deals with Eli Lilly, Novartis for up to $3B Isomorphic Labs, …

mwbn.bio

$3
OFF

Alphabet’s AI Unit Isomorphic Inks Drug Discovery Deals With Eli …

4 weeks from now

Jan 7, 2024 · Isomorphic Labs, Alphabet’s closely watched AI startup, has signed its first pharma partnerships, and will work with Eli Lilly and Novartis in deals that could be worth $3 billion, …

sfbn.org

FAQs about Isomorphic Labs signs AI drug discovery deals with Novartis, Lilly Coupon?

Will alphabet's 'isomorphic Labs' get a $3 billion deal?

Isomorphic Labs, Alphabet’s closely watched AI startup, has signed its first pharma partnerships, and will work with Eli Lilly and Novartis in deals that could be worth $3 billion, CEO Demis Hassabis exclusively told Endpoints News. ...

What is isomorphic labs doing with Eli Lilly & Novartis?

Isomorphic Labs, a unit of Google-parent Alphabet, announced strategic research collaborations with Eli Lilly and Novartis. The partnerships with Eli Lilly and Novartis will focus on small-molecule treatments and multiple targets. ...

How much is isomorphic labs worth?

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion. ...

What is alphabet & isomorphic?

The Alphabet company was created in 2021 to build on the success of AlphaFold, DeepMind’s AI that created a detailed database of proteins and eventually predicted the structure of more than 200m proteins. Isomorphic uses AI to accelerate drug discovery and find cures for some of the most devastating diseases. ...

Does isomorphic Labs work with Novartis?

Isomorphic Labs, a subsidiary of Alphabet Inc., on Monday said it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co. Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co. ...

Who is isomorphic labs?

Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. ...